Logo
Unionpedia
Communication
Get it on Google Play
New! Download Unionpedia on your Android™ device!
Free
Faster access than browser!
 

Efungumab and Medication

Shortcuts: Differences, Similarities, Jaccard Similarity Coefficient, References.

Difference between Efungumab and Medication

Efungumab vs. Medication

Efungumab (trade name Mycograb) is a drug developed by NeuTec Pharma (a subsidiary of Novartis), intended to treat invasive ''Candida'' infection in combination with amphotericin B. The European Medicines Agency has twice refused to grant marketing authorization for Mycograb, citing product safety and quality issues. A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease.

Similarities between Efungumab and Medication

Efungumab and Medication have 4 things in common (in Unionpedia): Intravenous therapy, Monoclonal antibody, Novartis, World Health Organization.

Intravenous therapy

Intravenous therapy (IV) is a therapy that delivers liquid substances directly into a vein (intra- + ven- + -ous).

Efungumab and Intravenous therapy · Intravenous therapy and Medication · See more »

Monoclonal antibody

Monoclonal antibodies (mAb or moAb) are antibodies that are made by identical immune cells that are all clones of a unique parent cell.

Efungumab and Monoclonal antibody · Medication and Monoclonal antibody · See more »

Novartis

Novartis International AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland.

Efungumab and Novartis · Medication and Novartis · See more »

World Health Organization

The World Health Organization (WHO; French: Organisation mondiale de la santé) is a specialized agency of the United Nations that is concerned with international public health.

Efungumab and World Health Organization · Medication and World Health Organization · See more »

The list above answers the following questions

Efungumab and Medication Comparison

Efungumab has 14 relations, while Medication has 369. As they have in common 4, the Jaccard index is 1.04% = 4 / (14 + 369).

References

This article shows the relationship between Efungumab and Medication. To access each article from which the information was extracted, please visit:

Hey! We are on Facebook now! »